Imaging Artificial Intelligence Vendor Elucid Raises $55M

Imaging artificial intelligence vendor Elucid raises $55M

<p>The Boston AI firm touted the “oversubscribed” Series D funding round, which included participation from an unnamed, publicly traded medical technology firm. </p>

Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform

What You Should Know Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative funding to approximately $185M. The round features participation from a new major, publicly traded medical device company—becoming Elucid’s fourth publicly traded strategic backer—alongside existing investors including IAG Capital Partners and Elevage Medical Technologies (a Patient ...

Elucid Raises $55 Million in Oversubscribed Series D Financing

BOSTON--(BUSINESS WIRE)-- #AIinHealthcare--Elucid, a medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease, today announced the raise of $55 million in an oversubscribed Series D financing. The round brings Elucid's total funding raised to date to approximately $185 million and includes new participation from a large medtech company, which joins as Elucid…